Meeting
2021 Gastrointestinal Cancers Symposium
Patient characteristics and survival outcomes in gastrointestinal cancers harboring RNF43 mutations or RSPO3 fusions: a retrospective analysis.
Authors
Paul Sackstein
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
Paul Sackstein , Garrett Buechner , Benjamin Adam Weinberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Other GI Cancer
Track
Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 473)
DOI
10.1200/JCO.2021.39.3_suppl.473
Abstract #
473
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC).
First Author: Emily Harrold
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2020 Gastrointestinal Cancers Symposium
Feasibility and clinical impact of routine molecular testing of gastrointestinal (GI) cancers at a tertiary center with a multigene, next generation sequencing (NGS) panel.
First Author: Giacomo Bregni
Poster
2018 ASCO Annual Meeting
MSI-high and MSI-stable colorectal carcinomas (CRC): A comprehensive genomic profiling (CGP) study.
First Author: Siraj Mahamed Ali